VIB Vermögen Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for VIB Vermögen.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Real Estate earnings growth	37.6%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18

Recent updates

VIB Vermögen's (ETR:VIH1) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 18

Should You Think About Buying VIB Vermögen AG (ETR:VIH1) Now?

Oct 11

VIB Vermögen AG (ETR:VIH1) Shares Fly 26% But Investors Aren't Buying For Growth

Sep 20

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

Mar 29

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Feb 11

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Sep 06

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Oct 15

VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

Mar 11

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Feb 18

You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Jan 19

Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Dec 25

Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

Dec 06

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Nov 18

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as VIB Vermögen has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

XTRA:VIH1 - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2025	118	40	99	99	N/A
3/31/2025	113	38	95	95	N/A
12/31/2024	107	36	91	91	N/A
9/30/2024	102	62	80	80	N/A
6/30/2024	98	87	68	68	N/A
3/31/2024	100	108	72	72	N/A
12/31/2023	103	130	75	75	N/A
9/30/2023	105	107	73	73	N/A
6/30/2023	108	84	71	71	N/A
3/31/2023	128	76	N/A	N/A	N/A
12/31/2022	128	54	68	68	N/A
9/30/2022	126	41	N/A	N/A	N/A
6/30/2022	126	49	74	74	N/A
3/31/2022	106	143	N/A	N/A	N/A
12/31/2021	102	30	75	75	N/A
9/30/2021	101	54	N/A	N/A	N/A
6/30/2021	98	53	69	71	N/A
3/31/2021	96	71	N/A	N/A	N/A
12/31/2020	94	66	64	65	N/A
9/30/2020	94	71	N/A	N/A	N/A
6/30/2020	93	67	64	64	N/A
3/31/2020	92	64	N/A	N/A	N/A
12/31/2019	91	63	69	69	N/A
9/30/2019	90	58	N/A	N/A	N/A
6/30/2019	89	60	67	67	N/A
3/31/2019	88	59	N/A	N/A	N/A
12/31/2018	87	58	N/A	61	N/A
9/30/2018	86	58	N/A	N/A	N/A
6/30/2018	85	53	N/A	61	N/A
3/31/2018	85	51	N/A	N/A	N/A
12/31/2017	84	52	N/A	59	N/A
9/30/2017	83	49	N/A	N/A	N/A
6/30/2017	82	50	N/A	57	N/A
3/31/2017	81	50	N/A	N/A	N/A
12/31/2016	80	47	N/A	58	N/A
9/30/2016	79	43	N/A	N/A	N/A
6/30/2016	78	44	N/A	56	N/A
3/31/2016	77	40	N/A	N/A	N/A
12/31/2015	75	40	N/A	54	N/A
9/30/2015	73	37	N/A	N/A	N/A
6/30/2015	72	32	N/A	N/A	N/A
3/31/2015	71	32	N/A	N/A	N/A
12/31/2014	70	31	N/A	48	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if VIH1's forecast earnings growth is above the savings rate (1.4%).

Earnings vs Market: Insufficient data to determine if VIH1's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if VIH1's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if VIH1's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if VIH1's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if VIH1's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/13 19:39
End of Day Share Price	2025/10/13 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

VIB Vermögen AG is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Andre Remke	Baader Helvea Equity Research
Gerhard Schwarz	Baader Helvea Equity Research
Paul May	Barclays

VIB Vermögen Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Price target decreased by 33% to €29.00

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

VIB Vermögen AG Provides Earnings Guidance for the Year 2022

Price target decreased to €49.98

Consensus forecasts updated

Consensus forecasts updated

Recent updates

New major risk - Revenue and earnings growth

VIB Vermögen AG (XTRA:VIH1) completed the acquisition of Institutional Business of Branicks Group AG (XTRA:DIC).

First half 2025 earnings released: EPS: €0.80 (vs €0.69 in 1H 2024)

VIB Vermögen AG Announces Board Changes

Upcoming dividend of €0.04 per share

VIB Vermögen AG, Annual General Meeting, Aug 06, 2025

Investor sentiment deteriorates as stock falls 16%

VIB Vermögen's (ETR:VIH1) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Dividend of €0.04 announced

VIB Vermögen AG announces Annual dividend, payable on August 11, 2025

VIB Vermögen AG to Report First Half, 2025 Results on Aug 14, 2025

VIB Vermögen AG (XTRA:VIH1) acquired remaining 5.12% stake in BBI Bürgerliches Brauhaus Immobilien AG.

Now 20% undervalued

Should You Think About Buying VIB Vermögen AG (ETR:VIH1) Now?

Investor sentiment improves as stock rises 15%

VIB Vermögen AG (ETR:VIH1) Shares Fly 26% But Investors Aren't Buying For Growth

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: €0.69 (vs €1.98 in 1H 2023)

VIB Vermögen AG, Annual General Meeting, Aug 14, 2024

VIB Vermögen AG to Report First Half, 2024 Results on Aug 27, 2024

Now 31% undervalued after recent price drop

Now 22% undervalued

New major risk - Revenue and earnings growth

Concerns Surrounding VIB Vermögen's (ETR:VIH1) Performance

Full year 2023 earnings released: EPS: €3.92 (vs €1.90 in FY 2022)

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

New minor risk - Financial data availability

VIB Vermögen AG, Annual General Meeting, Jul 11, 2024

New major risk - Financial data availability

When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Price target decreased by 33% to €29.00

VIB Vermögen AG to Report Fiscal Year 2023 Results on Mar 19, 2024

New major risk - Revenue and earnings growth

New minor risk - Earnings quality

First half 2023 earnings released

Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

VIB Vermögen AG to Report First Half, 2023 Results on Aug 03, 2023

Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 18%

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG Approves Distribute Dividend

Upcoming dividend of €0.85 per share

Second quarter 2022 earnings released

VIB Vermögen AG Provides Earnings Guidance for the Year 2022

VIB Vermögen Ag Announces Executive Changes, October 1, 2022

Upcoming dividend of €0.85 per share

Price target decreased to €49.98

Consensus forecasts updated

Consensus forecasts updated

Full year 2021 earnings: EPS misses analyst expectations

VIB Vermögen AG Confirms Earnings Guidance for the Year 2022

VIB Vermögen AG Proposes Dividend

VIB Vermögen AG Starts Marketing the 'Next Horizon' Development Project with Around 79,000 Sqm of Commercial Space in Erding

DIC Asset AG (XTRA:DIC) cancelled the acquisition of additional 40.95% stake in VIB Vermögen AG (XTRA:VIH1).

Price target increased to €44.00

Consensus forecasts updated

Price target increased to €40.17

Third quarter 2021 earnings released: EPS €0.65 (vs €0.61 in 3Q 2020)

Price target increased to €38.08

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Second quarter 2021 earnings released

Supervisory Board Member Rolf Klug has left the company

Supervisory Board Member Franz-Xaver Schmidbauer has left the company